financetom
Business
financetom
/
Business
/
Solo Brands to Resume Trading on NYSE, Update Ticker Symbol
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Solo Brands to Resume Trading on NYSE, Update Ticker Symbol
Jul 15, 2025 1:57 AM

04:31 AM EDT, 07/15/2025 (MT Newswires) -- Solo Brands (DTC) said Monday that the NYSE has withdrawn its delisting determination and will be lifting the trading suspension of the company's shares under the ticker symbol, "DTC," effective July 18.

In connection with the removal of the delisting determination, the company said it has withdrawn its appeal of the decision.

The company said that it continues to be out of compliance with rules requiring a share price of more than $1 and has until Aug. 25 to regain compliance.

The company also said it will update its ticker symbol to "SBDS," effective July 24.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Kingsway Pharmaceuticals Acquires Strategic Equity Stake in CIGA Healthcare to Expand Access to At-Home and Retail Diagnostic Testing
Kingsway Pharmaceuticals Acquires Strategic Equity Stake in CIGA Healthcare to Expand Access to At-Home and Retail Diagnostic Testing
Nov 17, 2025
BRISTOL, Tenn., Nov. 17, 2025 /PRNewswire/ -- Kingsway Pharmaceuticals, a U.S.-based consumer healthcare company specializing in nationally distributed OTC brands and private label solutions, announced today that it has acquired a strategic minority stake in CIGA Healthcare, a global diagnostics innovator supplying rapid tests and home diagnostic technologies to more than 70 countries. The investment forms a joint venture alignment...
Form 8.3
Form 8.3
Nov 17, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: BALYASNY ASSET MANAGEMENT L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...
Merlin Labs, Inc. and Inflection Point Acquisition Corp. IV Announce Upsizing of PIPE Investment to More Than $200 Million
Merlin Labs, Inc. and Inflection Point Acquisition Corp. IV Announce Upsizing of PIPE Investment to More Than $200 Million
Nov 17, 2025
Inflection Point and investors increase PIPE commitments to more than $200 million, including over $85 million of pre-funded PIPE capital BOSTON--(BUSINESS WIRE)-- Merlin Labs, Inc. (“Merlin”), a leading developer of assured, autonomous flight technology for defense customers, and Inflection Point Acquisition Corp. IV ( BACQ ) (“Inflection Point”) today announced a significant increase to their previously disclosed private investment...
Form 8.3
Form 8.3
Nov 17, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: BALYASNY ASSET MANAGEMENT L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...
Copyright 2023-2026 - www.financetom.com All Rights Reserved